Prestige Consumer Healthcare (NYSE: PBH) revenue
Prestige Consumer Healthcare reported revenue of $1,089m for fiscal 2026, 4.3% less than in fiscal 2025 ($1,138m). Since fiscal 2017 its revenue has grown by 23.4%, an average growth of 2.4% a year.
Prestige Consumer Healthcare's best year of the last 10 was fiscal 2025. The biggest drop was in fiscal 2019, −6.3%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2026 | $1,089m | −4.3% | $309.4m | 28.4% |
| 2025 | $1,138m | +1.1% | $336.8m | 29.6% |
| 2024 | $1,125m | −0.2% | $342.4m | 30.4% |
| 2023 | $1,128m | +3.8% | −$22.4m | −2.0% |
| 2022 | $1,087m | +15.2% | $329.9m | 30.4% |
| 2021 | $943.4m | −2.0% | $297.4m | 31.5% |
| 2020 | $963.0m | −1.3% | $291.2m | 30.2% |
| 2019 | $975.8m | −6.3% | $67.5m | 6.9% |
| 2018 | $1,041m | +18.0% | $215.5m | 20.7% |
| 2017 | $882.1m | — | $205.6m | 23.3% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Prestige Consumer Healthcare revenue compared with its sector
By revenue for its latest fiscal year, Prestige Consumer Healthcare ranks 145th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Prestige Consumer Healthcare, −4.3%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 143rd | Novavax | $1,123m | 64.7% |
| 144th | Waystar | $1,099m | 16.5% |
| 145th | Prestige Consumer Healthcare | $1,089m | −4.3% |
| 146th | Embecta | $1,080m | −3.8% |
| 147th | Acadia Pharmaceuticals | $1,072m | 11.9% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Prestige Consumer Healthcare
- How much revenue did Prestige Consumer Healthcare make in fiscal 2026?
- Prestige Consumer Healthcare reported revenue of $1,089m for fiscal 2026, compared with $1,138m in fiscal 2025.
- How much has the revenue of Prestige Consumer Healthcare grown?
- Between fiscal 2017 and fiscal 2026 it went from $882.1m to $1,089m: 23.4% more, an average growth of 2.4% a year.
- What was the best year for revenue at Prestige Consumer Healthcare?
- Of its last 10 fiscal years, fiscal 2025, with $1,138m.
- Where does Prestige Consumer Healthcare rank in its sector by revenue?
- It ranks 145th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Prestige Consumer Healthcare come from?
- From the annual report (Form 10-K) that Prestige Consumer Healthcare files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Prestige Consumer Healthcare files with the SEC. The filing for each fiscal year: 2026 · 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on Prestige Consumer Healthcare: the Prestige Consumer Healthcare page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.